Regulatory Dendritic Cells Induced by Mesenchymal Stem Cells Ameliorate Dextran Sodium Sulfate-Induced Chronic Colitis in Mice
Open Access
- 15 November 2018
- journal article
- research article
- Published by The Editorial Office of Gut and Liver in Gut and Liver
- Vol. 12 (6), 664-673
- https://doi.org/10.5009/gnl18072
Abstract
Background/Aims: Regulatory dendritic cells (rDCs), which can be induced by mesenchymal stem cells (MSCs), play an important role in inducing and maintaining homeostasis of regulatory T cells and exhibit anti-inflammatory functions. In this study, we investigated whether MSCs could differentiate DCs into rDCs and compared the therapeutic effects of rDCs and MSCs on dextran sodium sulfate (DSS)-induced chronic colitis mice. Methods: Immature DCs (imDCs) and lipopolysaccharide (LPS)-treated mature DCs (mDCs) were co-cultured with MSCs for 48 hours, and then the profiles of surface markers and cytokines and regulatory roles of these DCs for primary splenocytes were analyzed. In addition, the therapeutic effects of MSCs and DCs co-cultured with MSCs were compared in chronic colitis mice. Results: After co-culture of imDCs (MSC-DCs) or LPS-treated mDCs (LPS+MSC-DCs) with MSCs, the expression of CD11c, CD80, CD86, interleukin 6 (IL-6), tumor necrosis factor-alpha (TNF-alpha), and interferon-gamma (IFN-gamma), was decreased, but that of CD11b, IL-10, and transforming growth factor-beta (TGF-beta) was increased. Furthermore, MSC-DCs and LPS+MSC-DCs induced the expression of CD4, CD25, and Foxp3 in primary splenocytes isolated from mice. In DSS-induced colitis mice, MSCs and MSC-DCs increased colon length, body weight, and survival rate and induced histological improvement. Moreover, in the colon tissues, the expression of IL-6, TNF-alpha, and IFN-gamma decreased, but that of IL-10, TGF-beta, and Foxp3 increased in the MSC- and MSC-DC-injected groups. Conclusions: Our data suggest that MSCs differentiate DCs into rDCs, which ameliorate chronic colitis. Thus, rDCs stimulated by MSCs may be therapeutically useful for the treatment of chronic inflammatory diseases.This publication has 32 references indexed in Scilit:
- Novel Mechanism of Inhibition of Dendritic Cells Maturation by Mesenchymal Stem Cells via Interleukin-10 and the JAK1/STAT3 Signaling PathwayPLOS ONE, 2013
- Mesenchymal stem cells: a double-edged sword in regulating immune responsesCell Death & Differentiation, 2012
- Mesenchymal Stem Cell treatment for autoimmune diseases: a critical reviewBiological Research, 2012
- A protocol for isolation and culture of mesenchymal stem cells from mouse compact boneNature Protocols, 2010
- MSCs inhibit monocyte-derived DC maturation and function by selectively interfering with the generation of immature DCs: central role of MSC-derived prostaglandin E2Blood, 2009
- Mesenchymal stem cells induce mature dendritic cells into a novel Jagged-2–dependent regulatory dendritic cell populationBlood, 2009
- Effects of Human Mesenchymal Stem Cells on the Differentiation of Dendritic Cells from CD34+CellsStem Cells and Development, 2007
- The immunological and genetic basis of inflammatory bowel diseaseNature Reviews Immunology, 2003
- The Role of IL-10 and TGF-β in the Differentiation and Effector Function of T Regulatory CellsInternational Archives of Allergy and Immunology, 2002
- Immature, but not inactive: the tolerogenic function of immature dendritic cellsImmunology & Cell Biology, 2002